Home>>Plant Biology>> Plant Growth Regulators>>N6-(δ2-Isopentenyl)adenosine

N6-(δ2-Isopentenyl)adenosine (Synonyms: 2-iPA, Isopentenyladenosine, N6-Isopentenyladenine riboside, N6-Isopentenyladenosine, N6-(2-Isopentenyl)adenosine, NSC 105546, Riboprine, SQ 22,558)

Catalog No.GC41280

N6-(δ2-Isopentenyl)adenosine (Riboprine), an RNA modification found in cytokinins, which regulate plant growth/differentiation, and a subset of tRNAs, where it improves the efficiency and accuracy of translation. N6-(δ2-Isopentenyl)adenosine, an end product of the mevalonate pathway, is an autophagy inhibitor with an interesting anti-melanoma activity.

Products are for research use only. Not for human use. We do not sell to patients.

N6-(δ2-Isopentenyl)adenosine Chemical Structure

Cas No.: 7724-76-7

Size Price Stock Qty
25mg
$49.00
In stock
50mg
$83.00
In stock
100mg
$150.00
In stock
250mg
$299.00
In stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Customer Reviews

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

N6-(δ2-Isopentenyl)adenosine is a precursor in the biosynthesis of the plant hormone N6-(δ2-isopentenyl)adenine . N6-(δ2-isopentenyl)adenine may be converted to the cytokinin trans-zeatin by cytochrome P450 mono-oxygenases. Cytokinins, including N6-(δ2-isopentenyl)adenine and trans-zeatin, regulate diverse events in plant growth and development. N6-(δ2-Isopentenyl)adenosine can also alter post-transcriptional processes in mammalian cells, altering proliferation and apoptosis.

Reviews

Review for N6-(δ2-Isopentenyl)adenosine

Average Rating: 5 ★★★★★ (Based on Reviews and 23 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for N6-(δ2-Isopentenyl)adenosine

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.